| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $300.0K | $0 | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | $100.0K | $0 | $0 |
| Gross Margin % | 33.3% | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$729.3M | -$509.7M | -$446.9M |
| Operating Margin % | -243100.0% | — | — |
| Net Income (GAAP) | -$618.2M | -$536.8M | -$457.9M |
| EBITDA (Normalized) | -$666.3M | -$444.1M | -$446.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$432.9M | -$368.6M | -$271.6M |
| Capital Expenditures (CapEx) | $78.8M | $82.0M | $0 |
| Free Cash Flow (FCF) | -$511.7M | -$450.6M | -$271.6M |
| FCF Margin % | -170566.7% | — | — |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | -31.2% |
| Cash & Short-Term Equivalents | $1.02B | $834.5M | — |
| Total Debt (Short + Long Term) | $79.5M | $64.0M | $438.7M |
| Total Stockholders' Equity | $2.20B | $752.6M | $899.9M |